metformin has been researched along with Hypophosphatemia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsitsios, T | 1 |
| Sotirakopoulos, N | 1 |
| Armentzioiou, K | 1 |
| Kalogiannidou, I | 1 |
| Kolaggis, A | 1 |
| Mavromatidis, K | 1 |
1 other study available for metformin and Hypophosphatemia
| Article | Year |
|---|---|
Metformin induced severe hypophosphatemia in a patient on hemodialysis.
Topics: Aged; Biomarkers; Diabetes Mellitus; Down-Regulation; Fatigue; Female; Humans; Hypoglycemic Agents; | 2010 |